ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2020

Jun 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2020-06-16

Reporting Person: SOUTHWELL DAVID P (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-16	Stock Option (Right to Buy)	$19.9	A	20000	Acquired	2030-06-16	Common Stock (20000)	Direct

Footnotes

F1: This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021.